期刊文献+

姜黄素对哮喘大鼠气道炎症与核因子κB表达的影响 被引量:15

Effect of curcumin on airway inflammation and the expression of nuclear factor kappa-B in rats with asthma
下载PDF
导出
摘要 目的:探讨姜黄素对支气管大鼠气道炎症及核因子-κBNF-κB的影()响。方法:Wistar大鼠随机分为正常对照组、哮喘模型组、姜黄素组各12只,采用卵蛋白OVA等致敏大鼠哮喘模型,观察3组动物哮喘发作症()状、气道炎症情况及免疫组化染色后NF-κB的核着色情况。结果:哮喘模型组大鼠哮喘发作症状最明显,姜黄素组大鼠症状轻,正常对照组无症状。哮喘模型组支气管周围明显炎细胞浸润,且以浆细胞、嗜酸性粒细胞浸润为主,姜黄素组较哮喘模型组明显减轻,正常对照组无明显炎细胞浸润。肺泡灌洗液总细胞数及嗜酸性粒细胞哮喘模型组明显高于正常对照组和姜黄素组。肺组织石蜡切片免疫组化发现哮喘模型组NF-κB的核着色最强,姜黄素组较弱,正常对照组微弱表达。结论:姜黄素可抑制哮喘的慢性气道炎症,其机制可能与姜黄素抑制哮喘大鼠NF-κB的活性有关。 AIM: To investigate the influence of curcumin on airway inflammation and nuclear factor kappa B (NF κ B) in rats with asthma.METHODS: Wistar rats were randomly divided into three groups: normal control group (n=12), asthmatic model group (n=12) and curcumin treatment group (n=12).The asthmatic models were established by ovalbumin (OVA).The symptoms of asthmatic attack and airway inflammation as well as the NF κ B nuclear pigmenting after immohistochemical staining were observed.RESULTS: The symptoms of asthmatic attack was the most obvious in the asthmatic model group, but mild in the curcumin treatment group, and no symptom was observed in the normal control group. In the asthmatic model group, there were obvious infiltrations of inflammatory cells around the bronchi, and most of them were infiltrations of plasmacytes and eosinophils, which were remarkably relieved in the curcumin treatment group, and there was no obvious infiltration of inflammatory cells in the normal control group. The total cell amount in bronchoalveolar lavage fluid and eosinophil were obviously higher in the asthmatic model group than in the curcumin treatment group and normal control group. Lung tissue paraffin section immunohistochemistry showed that the nuclear pigmenting of NF κ B was the strongest in the asthmatic model group, weaker in the curcumin treatment group, and only slight expression in the normal control group.CONCLUSION: Curcumin can inhibit asthmatic chronic airway inflammation, and its mechamism may be correlated with the inhibition of curcumin to the activity of NF κ B in rats.
出处 《中国临床康复》 CSCD 北大核心 2005年第11期102-104,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献10

  • 1吕国平,崔德健,郭英江,谭剑.介绍一种建立大鼠哮喘模型的实验方法[J].中华结核和呼吸杂志,1995,18(6):377-378. 被引量:187
  • 2鲍华英,陈荣华.姜黄素的研究进展[J].国外医学(儿科学分册),2003,30(5):254-256. 被引量:90
  • 3Barnes PJ, Aadcock IM. NF-Kappa B: a pivotal role in asthma and a new target therapy. Trends Pharmacol Sci 1997; 18(2):46-50.
  • 4Punithavathi D, Venkatesan N, Babu M, et al. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 2003;139(7): 1342-50.
  • 5Bharti AC, Donato N, Singh S, et al. Curcumin diferuloylmethane down-regulates the constitutive activation of nuclear factor-κappa B and IκappaBalpha kinase in human multiple myeloma cells, leading to supression of proliferation and induction of apoptosis. Blood 2003:101 (3): 1053-62.
  • 6Christman JW, Sadikot RT, Blacknell TS, et al. The role of nuclear factor-Kappa B in pulmonarv diseases. Chest 2000; 117(5): 1482-7.
  • 7庞敏,杜永成,许建英.核因子-κB抑制剂及其在肺部疾病中的应用[J].国外医学(内科学分册),2003,30(7):301-304. 被引量:2
  • 8Shahed AR, Jones E, Shoskes D, et al. Quesrcetin and curcumin up-regulate anti-oxidant gene expression in rat kidney after ureteral obstruction or ischemia reperfusion injury. Transplant Proc 2001,33 (6):2988.
  • 9Ram A, Dss M, Ghosh B. Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitised guinea pigs. Biol Pharm Bull 2003; 26 (7): 1021-4.
  • 10Kobayashi T, Hashimoto S, Horie T, et al. Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5)and granulocyte-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 1997; 54(7): 819-24.

二级参考文献43

  • 1Hart LA, Krishnan VL, Adcock IM, et al. [J].Am J Respir Crit Care Med, 1998, 158 (5Ptl):1585-1592.
  • 2Schwartz MD, Moore EE, Moore FA, et al. [ J]. Crit Care Med, 1996,24 : 1285-1292.
  • 3Zhang XY, Shimura S, Masuda T, et al. [ J ]. Am J Respir Crit Care Med, 2000,162:1561-1568.
  • 4Nishikawa M, Kakemizu N, Ito T, et al. [J]. Am J Respir Cell Mol Biol, 1999 , 20 :189-198.
  • 5Hancox R J, Stevens DA, Adcock IM, et al. [ J]. Thorax, 1999,54(6) :488-492.
  • 6Hart L, Lim S, Adcock L, et al. [J]. Am J Respir Crit Care Med, 2000,16(1) :224-231.
  • 7Jue DM, Jeon KI, Jeong JY. [J]. J Korean Med Sci, 1999,14(3) :231-238.
  • 8Bitko V, Velazquez A, Yang L, et al. [J]. Virology, 1997,232(2) :369-378.
  • 9Parmentier M, Drost E, Hirani N, et al. [J]. Am J Respir Crit Care Med, 1999,159:A286.
  • 10Schins RP, McAlinden A, MacNee W, et al. [J].Toxicol Appl Pharmacol, 2000,167 (2) : 107-117.

共引文献275

同被引文献192

引证文献15

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部